This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20171107 arb minutes"

From HL7Wiki
Jump to navigation Jump to search
 
(4 intermediate revisions by the same user not shown)
Line 15: Line 15:
 
-->
 
-->
 
=ARB - Meeting (Date in Title)=  
 
=ARB - Meeting (Date in Title)=  
{{:Spring ARB Logistics}}
+
 
 
==Agenda==
 
==Agenda==
 
#Call to order
 
#Call to order
Line 26: Line 26:
 
#Methodology
 
#Methodology
 
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FMG_SyS_HL7%2520Project%2520Scope%2520Statement%2520v2017.1_2017_09_01.docx PHER Syndromic Surveillance Messaging Guide] Dave Trepanier  
 
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FMG_SyS_HL7%2520Project%2520Scope%2520Statement%2520v2017.1_2017_09_01.docx PHER Syndromic Surveillance Messaging Guide] Dave Trepanier  
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FOASIS%2520HAVE%2520PSS%2520draft%25202017-09-20.docx PAVE project]
+
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FOASIS%2520HAVE%2520PSS%2520draft%25202017-09-20.docx HAVE project]
 
#*FHIR Artifact Curation Process: (From Rene Spronk)
 
#*FHIR Artifact Curation Process: (From Rene Spronk)
 
#**At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
 
#**At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
Line 41: Line 41:
 
| width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 ARB Work Group  Meeting Minutes''' <br/>
 
| width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 ARB Work Group  Meeting Minutes''' <br/>
 
'''Location:  [[spring_ARB_Logistics| Telcon]]'''
 
'''Location:  [[spring_ARB_Logistics| Telcon]]'''
| width="50%" colspan="3" align="left" style="background:#f0f0f0;"|'''Date: CCYYMMDD'''<br/> '''Time: 4:00pm U.S. Eastern'''
+
| width="50%" colspan="3" align="left" style="background:#f0f0f0;"|'''Date: 20171107'''<br/> '''Time: 4:00pm U.S. Eastern'''
 
|-
 
|-
 
| width="10%" colspan="1" align="right"|'''Facilitator'''
 
| width="10%" colspan="1" align="right"|'''Facilitator'''
| width="35%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]]/[[User:Lconstab |Constable, Lorraine]]   
+
| width="35%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]]  
 
| width="10%" colspan="1" align="right"|'''Note taker(s)'''
 
| width="10%" colspan="1" align="right"|'''Note taker(s)'''
| width="30%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]]//[[User:Lconstab |Constable, Lorraine]]   
+
| width="30%" colspan="1" align="left"|[[User:Ajulian | Julian, Tony]]  
 
|-
 
|-
 
| border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"|
 
| border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"|
Line 57: Line 57:
 
|colspan="2"|NEHTA
 
|colspan="2"|NEHTA
 
|-  
 
|-  
|.||[[User:Lconstab |Constable, Lorraine]]     
+
|X||[[User:Lconstab |Constable, Lorraine]]     
 
|colspan="2"|Constable Consulting Inc.
 
|colspan="2"|Constable Consulting Inc.
 
|-  
 
|-  
Line 63: Line 63:
 
|colspan="2"| AEGIS
 
|colspan="2"| AEGIS
 
|-
 
|-
|.||[[User:Ajulian | Julian, Tony]]       
+
|X||[[User:Ajulian | Julian, Tony]]       
 
|colspan="2"|Mayo Clinic
 
|colspan="2"|Mayo Clinic
 
|-  
 
|-  
|.||Knapp, Paul
+
|R||Knapp, Paul
 
|colspan="2"| Pknapp Consulting
 
|colspan="2"| Pknapp Consulting
 
|-  
 
|-  
|.||Kubick, Wayne
+
|R||Kubick, Wayne
 
|colspan="2"|HL7 CTO
 
|colspan="2"|HL7 CTO
 
|-
 
|-
Line 78: Line 78:
 
|colspan="2"|Accenture
 
|colspan="2"|Accenture
 
|-  
 
|-  
|.||Milosevic, Zoran
+
|X||Milosevic, Zoran
 
|colspan="2"|Deontik Pty Ltd
 
|colspan="2"|Deontik Pty Ltd
 
|-
 
|-
|.||[[User:Astechishin| Stechishin,Andy]]
+
|X||[[User:Astechishin| Stechishin,Andy]]
 
|colspan="2"|CANA Software and Service Ltd.
 
|colspan="2"|CANA Software and Service Ltd.
 
|-
 
|-
 
|colspan="4" align="center"|Guests             
 
|colspan="4" align="center"|Guests             
 
|-  
 
|-  
|.|| Nelson, Dale
+
|X||Hicks, Peter
|colspan="2"| Accenture
+
|colspan="2"|U.S. CDC
 +
|-
 +
|X|| Lamb, Emilie
 +
|colspan="2"| syndromic.org
 
|-
 
|-
|.||Grow, Richard
+
|X||Robertson, Scott
|colspan="2"|U.S. Department of Veterans affairs
+
|colspan="2"|Kaiser Permanente
 
|-
 
|-
 
|.||  
 
|.||  
Line 113: Line 116:
  
 
==Minutes==
 
==Minutes==
 +
==Agenda==
 +
#Approval of Agenda and [[20171024_arb_minutes | Minutes]]
 +
#'''MOTION '''to approve the minute of the  20171024 ARB meeting (Lorraine/Andy )
 +
#'''Vote''' 3-0-1
 +
#Management
 +
#Governance
 +
#Methodology
 +
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FMG_SyS_HL7%2520Project%2520Scope%2520Statement%2520v2017.1_2017_09_01.docx PHER Syndromic Surveillance Messaging Guide] Dave Trepanier
 +
#**External development: 
 +
#***Majority of the content is from the Previous Guide
 +
#***PHER is developing the guide.
 +
#***Based on HL7 V2.5.1
 +
#**'''Motion''' to Approve (Lorraine/Andy S)
 +
#**'''Vote''' 4-0-0
 +
#*[https://gforge.hl7.org/gf/project/arbgeneral/scmsvn/?action=browse&path=%2F%2Acheckout%2A%2Ftrunk%2FOASIS%2520HAVE%2520PSS%2520draft%25202017-09-20.docx HAVE project]
 +
#**Lorraine: Are we balloting an HL7 guide, or the oasis document
 +
#**Scott: Balloting Appendix B:Creating a query based on V2.8 using OASIS content.
 +
#**Refer to TSC Exec:  Developing an HL7 IG to be imbeded in the OASIS document.
 +
#*FHIR Artifact Curation Process: (From Rene Spronk)
 +
#**At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
 +
#**I asked Lloyd, and he states that the GOM does allow a third party to bring forward an artifact (e.g. en new FHIR resource, a profile) for inclusion in HL7's standard. Let's assume the "international society for peadiatrics" has defined a new FHIR resource or profile; they organize their own test events; dowzens of vendors have implemented it - and all of that without any official involvement of HL7 international.
 +
#**Now they bring this artifact to HL7.
 +
#**What's the process ArB/TSC would follow in dealing with that artifact? Where would it end up? Would it have draft status within HL7, or will it have some higher maturity level because it has already been implemented/tested? Who will get to decide this?
 +
#**(note that some affiliates face this issue regularly, so its not really a hypothetical question). If there are no answers to the above questions, if you were to speculate, how should the process look like ?
 +
#**Answer to Rene:
 +
#***An HL7 Work Group would create an HL7 project to bring in the material.
 +
#***ARB would review
 +
#****the external content and the Project Scope Statement to ensure the content is appropriate.
 +
#****verify that the appropriate Work Groups are engaged.
 +
#***The material would come in as DRAFT or STU and have to follow the established rules for balloting and maturity level.
 +
#***The fact it has been implemented and tested outside of HL7 is no guarantee that it will test in HL7.
  
 +
#Other business and planning
 +
#*[http://gforge.hl7.org/gf/project/ARBgeneral/tracker/?action=TrackerItemBrowse&tracker_id=871 Open issues]
 +
#Adjournment
 +
#*Adjourned at 5:00pm U.S. Eastern
  
 +
[[User:Ajulian|Tony Julian]] ([[User talk:Ajulian|talk]]) 10:01, 8 November 2017 (EST)
  
 
[[Category:2017 ARB Minutes]]
 
[[Category:2017 ARB Minutes]]

Latest revision as of 15:01, 8 November 2017

ARB - Meeting (Date in Title)

Agenda

  1. Call to order
  2. Roll Call
  3. Approval of Agenda and Minutes
  4. Management
    1. Mission and Charter Review - Due in fall WGM
    2. Decision Making Procedures review - due in fall WGM
  5. Governance
  6. Methodology
    • PHER Syndromic Surveillance Messaging Guide Dave Trepanier
    • HAVE project
    • FHIR Artifact Curation Process: (From Rene Spronk)
      • At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
      • I asked Lloyd, and he states that the GOM does allow a third party to bring forward an artifact (e.g. en new FHIR resource, a profile) for inclusion in HL7's standard. Let's assume the "international society for peadiatrics" has defined a new FHIR resource or profile; they organize their own test events; dowzens of vendors have implemented it - and all of that without any official involvement of HL7 international. #**Now they bring this artifact to HL7.
      • What's the process ArB/TSC would follow in dealing with that artifact? Where would it end up? Would it have draft status within HL7, or will it have some higher maturity level because it has already been implemented/tested? Who will get to decide this?
      • (note that some affiliates face this issue regularly, so its not really a hypothetical question). If there are no answers to the above questions, if you were to speculate, how should the process look like ?
  1. Other business and planning
  2. Adjournment

Meeting Information

HL7 ARB Work Group Meeting Minutes

Location: Telcon

Date: 20171107
Time: 4:00pm U.S. Eastern
Facilitator Julian, Tony Note taker(s) Julian, Tony
Attendee Name Affiliation
. Bond,Andy NEHTA
X Constable, Lorraine Constable Consulting Inc.
. Hyland, Mario AEGIS
X Julian, Tony Mayo Clinic
R Knapp, Paul Pknapp Consulting
R Kubick, Wayne HL7 CTO
. Loyd, Patrick ICode Solutions
. Lynch, Cecil Accenture
X Milosevic, Zoran Deontik Pty Ltd
X Stechishin,Andy CANA Software and Service Ltd.
Guests
X Hicks, Peter U.S. CDC
X Lamb, Emilie syndromic.org
X Robertson, Scott Kaiser Permanente
.
Legend
X Present
. Absent
R Regrets
Quorum Requirements (Co-chair + 3) Met: Yes

Minutes

Agenda

  1. Approval of Agenda and Minutes
  2. MOTION to approve the minute of the 20171024 ARB meeting (Lorraine/Andy )
  3. Vote 3-0-1
  4. Management
  5. Governance
  6. Methodology
    • PHER Syndromic Surveillance Messaging Guide Dave Trepanier
      • External development:
        • Majority of the content is from the Previous Guide
        • PHER is developing the guide.
        • Based on HL7 V2.5.1
      • Motion to Approve (Lorraine/Andy S)
      • Vote 4-0-0
    • HAVE project
      • Lorraine: Are we balloting an HL7 guide, or the oasis document
      • Scott: Balloting Appendix B:Creating a query based on V2.8 using OASIS content.
      • Refer to TSC Exec: Developing an HL7 IG to be imbeded in the OASIS document.
    • FHIR Artifact Curation Process: (From Rene Spronk)
      • At the upcoming FHIR DevDays in Amsterdam i'll be presenting a talk about the "creation and curation of FHIR profiles, process & governance". I've collected the process / governance descriptions from a number of affiliates and other organisations that create or curate (i.e. the validation/vetting of profiles created by others) FHIR artifacts.
      • I asked Lloyd, and he states that the GOM does allow a third party to bring forward an artifact (e.g. en new FHIR resource, a profile) for inclusion in HL7's standard. Let's assume the "international society for peadiatrics" has defined a new FHIR resource or profile; they organize their own test events; dowzens of vendors have implemented it - and all of that without any official involvement of HL7 international.
      • Now they bring this artifact to HL7.
      • What's the process ArB/TSC would follow in dealing with that artifact? Where would it end up? Would it have draft status within HL7, or will it have some higher maturity level because it has already been implemented/tested? Who will get to decide this?
      • (note that some affiliates face this issue regularly, so its not really a hypothetical question). If there are no answers to the above questions, if you were to speculate, how should the process look like ?
      • Answer to Rene:
        • An HL7 Work Group would create an HL7 project to bring in the material.
        • ARB would review
          • the external content and the Project Scope Statement to ensure the content is appropriate.
          • verify that the appropriate Work Groups are engaged.
        • The material would come in as DRAFT or STU and have to follow the established rules for balloting and maturity level.
        • The fact it has been implemented and tested outside of HL7 is no guarantee that it will test in HL7.
  1. Other business and planning
  2. Adjournment
    • Adjourned at 5:00pm U.S. Eastern

Tony Julian (talk) 10:01, 8 November 2017 (EST)